Wave Life Sciences (WVE) Operating Margin Growth (3y) (2018 - 2026)
Wave Life Sciences (WVE) Operating Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - | 15,241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,241.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 163,398.00 |
| Jun 30, 2024 | 125,700.00 |
| Dec 31, 2023 | 25,685.00 |
| Sep 30, 2023 | 100,657.00 |
| Jun 30, 2023 | 117,086.00 |
| Mar 31, 2023 | 96,723.00 |
| Dec 31, 2022 | -99,377.00 |
| Sep 30, 2022 | -1.18 Mn |
| Jun 30, 2022 | -1.06 Mn |
| Mar 31, 2022 | -59,094.00 |
| Dec 31, 2021 | -69,388.00 |
| Sep 30, 2021 | 83,004.00 |
| Jun 30, 2021 | -68,513.00 |
| Dec 31, 2020 | 251,656.00 |
| Sep 30, 2020 | 100,649.00 |
| Jun 30, 2020 | 97,209.00 |
| Mar 31, 2020 | 407,451.00 |
| Dec 31, 2019 | 21,507.00 |